ARCC vs LLY · P/E 11, $15.86B cap vs P/E 39, rev $65.18B
Ares Capital Corporation (ARCC) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Ares Capital Corporation (ARCC) is a asset management company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
ARCC does not have a complete income-statement cache yet.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ARCC currently screens at market cap $15.86B and trailing P/E 11.2. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ARCC and LLY stock pages for the full models.
Not investment advice.